BIOTECHNOLOGICAL METHODS FOR THE PRODUCTION OF VACCINES AND ANTIVIRAL PREPARATIONS
Vol. 6 No. 6 (2026): Eurasian Journal of Academic Research 137-141
Abstract
This article discusses the role of biotechnology in the development and production of vaccines and antiviral preparations. The scientific principles and practical applications of modern biotechnological methods used in preventing and controlling viral diseases are analyzed. Particular attention is given to recombinant DNA technology, cell culture techniques, genetic engineering, and mRNA-based platforms employed in vaccine development. In addition, the production of antiviral agents through biotechnological approaches, including monoclonal antibodies, interferons, and antiviral proteins, is examined. The advantages, limitations, and future prospects of these technologies in strengthening global health security and improving responses to emerging infectious diseases are also highlighted.
Keywords:
References
Plotkin S. A., Orenstein W. A., Offit P. A., Edwards K. M. Plotkin's Vaccines. 8th ed. Philadelphia: Elsevier, 2024. – 1824 p.
Rappuoli R., Aderem A. A 2020 vision for vaccines against HIV, tuberculosis and malaria // Nature. 2011. Vol. 473. – P. 463–469.
Krammer F. SARS-CoV-2 vaccines in development // Nature. 2020. Vol. 586. – P. 516–527.
Abbas A. K., Lichtman A. H., Pillai S. Cellular and Molecular Immunology. 10th ed. Philadelphia: Elsevier, 2021. – 560 p.
Murphy K., Weaver C. Janeway's Immunobiology. 10th ed. New York: Garland Science, 2022. – 928 p.
Walsh G. Biopharmaceuticals: Biochemistry and Biotechnology. 3rd ed. Chichester: Wiley, 2018. – 536 p.
World Health Organization. Global Vaccine Action Plan and Immunization Agenda 2030. Geneva: WHO, 2021.
Readership
Downloads
Published
Issue
Section
How to Cite
